Organigram Global Research and Development Expenses 2019-2024 | OGI
Organigram Global research and development expenses from 2019 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Organigram Global Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $8 |
| 2023 | $10 |
| 2022 | $5 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| Organigram Global Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2 |
| 2024-09-30 | $1 |
| 2024-06-30 | $2 |
| 2024-03-31 | $2 |
| 2023-12-31 | $3 |
| 2023-09-30 | $3 |
| 2023-05-31 | $3 |
| 2023-02-28 | $2 |
| 2022-11-30 | $2 |
| 2022-08-31 | $2 |
| 2022-05-31 | $1 |
| 2022-02-28 | $1 |
| 2021-11-30 | $1 |
| 2021-08-31 | |
| 2021-05-31 | |
| 2021-02-28 | |
| 2020-11-30 | |
| 2020-08-31 | |
| 2020-05-31 | |
| 2020-02-29 | |
| 2019-11-30 | |
| 2019-08-31 | |
| 2019-05-31 | |
| 2019-02-28 | |
| 2018-11-30 | |
| 2018-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.144B | $0.117B |
| Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO. | |||